Compare Fabrinet (FN) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fabrinet vs Health Care Select Sector SPDR Fund — how do they compare? Fabrinet trades at $460.67 (market cap $17.44B), while Health Care Select Sector SPDR Fund trades at $161.38. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Fabrinet nearer its low. Which is the better fit depends on your goals.
| FN | XLV | |
|---|---|---|
Market Cap | $17.44B | — |
Sector | Technology | — |
52-Week High | $746.47 | $164.48 |
52-Week Low | $277.04 | $129.01 |
Enterprise Value | $16.50B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fabrinet (FN) trades at $460.16, down 4.69% with a bearish technical signal despite strong fundamentals. The company reported consistent earnings beats with Q1 2026 EPS of $3.72 exceeding expectations, driven by 39% YoY revenue growth in optical communications. Analyst consensus remains strongly bullish with 18 buy ratings and a $733 price target, though technical indicators show selling pressure with support at $448.
The outlook remains positive given Fabrinet's strategic position in AI infrastructure and optical communications, with projected revenue growth to $4.2B in 2026. Key risks include premium valuation multiples and supply chain constraints, but the debt-free balance sheet and expanding margins support long-term growth potential in the AI-driven data center market.
XLV trades at $161.47, up 2.01% with a bullish technical signal from moving averages. The healthcare ETF benefits from State Street's upgraded sector outlook and strong performance from holdings like Johnson & Johnson. Technical indicators show support at $156-158 with resistance at $159-161, while RSI readings suggest neutral momentum.
The outlook remains positive as healthcare gains favor for defensive qualities amid market volatility. Key risks include patent expirations and regulatory pressures, but diversified exposure and innovation in biotech/pharma support long-term growth potential. Analyst sentiment favors healthcare for stability and innovation-driven returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fabrinet
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
